DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2JWsyLH
via IFTTT